I
Ivo W. Tremont-Lukats
Researcher at University of Texas MD Anderson Cancer Center
Publications - 34
Citations - 3436
Ivo W. Tremont-Lukats is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Cancer & Temozolomide. The author has an hindex of 16, co-authored 33 publications receiving 2957 citations. Previous affiliations of Ivo W. Tremont-Lukats include Medical University of South Carolina & Houston Methodist Hospital.
Papers
More filters
Journal ArticleDOI
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Mark R. Gilbert,James J. Dignam,Terri S. Armstrong,Terri S. Armstrong,Jeffrey S. Wefel,Deborah T. Blumenthal,Michael A. Vogelbaum,Howard Colman,Arnab Chakravarti,Stephanie L. Pugh,Minhee Won,Robert Jeraj,Paul D. Brown,Kurt A. Jaeckle,David Schiff,Volker W. Stieber,David Brachman,Maria Werner-Wasik,Ivo W. Tremont-Lukats,Erik P. Sulman,Kenneth Aldape,Walter J. Curran,Minesh P. Mehta +22 more
TL;DR: First-line use of bevacizumab did not improve overall survival in patients with newly diagnosed glioblastoma, and progression-free survival was prolonged but did not reach the prespecified improvement target.
Journal ArticleDOI
Brain metastasis from prostate carcinoma: The M. D. Anderson Cancer Center experience.
Ivo W. Tremont-Lukats,George C. Bobustuc,George K. Lagos,Konstantinos Lolas,Athanassios P. Kyritsis,Vinay K. Puduvalli +5 more
TL;DR: The objective of this study was to estimate the incidence and describe distribution, clinical presentation, and prognosis of brain metastases in patients with prostrate carcinoma who were seen at The University of Texas M. D. Anderson Cancer Center.
Journal ArticleDOI
Systemic administration of local anesthetic agents to relieve neuropathic pain
TL;DR: Lidocaine and oral analogs were safe drugs in controlled clinical trials for neuropathic pain, were better than placebo, and were as effective as other analgesics.
Journal ArticleDOI
Systemic Administration of Local Anesthetics to Relieve Neuropathic Pain: A Systematic Review and Meta-Analysis
TL;DR: Lidocaine and mexiletine produced no major adverse events in controlled clinical trials, were superior to placebo to relieve neuropathic pain, and were as effective as other analgesics used for this condition.
Journal ArticleDOI
Neurocognitive and functional assessment of patients with brain metastases: A pilot study
Mary A. Herman,Ivo W. Tremont-Lukats,Christina A. Meyers,Dianna D. Trask,Carrie Froseth,Markus F. Renschler,Minesh P. Mehta +6 more
TL;DR: Neurocognitive test batteries can and should be used in patients with brain metastases enrolled in clinical trials, and most patients demonstrated impairment in memory and fine motor domains.